Buys
Open market- Shares
- Avg price
- Total value
Paula Soteropoulos - Director at Dianthus Therapeutics, Inc. /DE/
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- DNTH on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Paula Soteropoulos in Dianthus Therapeutics, Inc. /DE/
Sells
Open market- Shares
- -28,792
- Avg price
- $78.25
- Total value
- -$2,252,894
Net
Past year- Shares
- -28,792
- Share %
- -100%
- Total value
- -$2,252,894
Reported holdings for Paula Soteropoulos in Dianthus Therapeutics, Inc. /DE/
Form 4 holding
Director
Dianthus Therapeutics, Inc. /DE/
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 08 May 2026
- Price
- $85.47
- Ownership
- Direct
Form 4 holding
Director
Dianthus Therapeutics, Inc. /DE/
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 6,090
- Estimated value
- Report date
- 21 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Paula Soteropoulos in Dianthus Therapeutics, Inc. /DE/
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.